Alirocumab Biosimilar - Research Grade,ichor.bio,ICH4016
Detects human PCSK9. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Alirocumab.
Host
Humanized
Reactivity
Human
Platform ID
BAB820384171
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameAlirocumab Biosimilar - Research Grade
Cat. No.ICH4016
Accession NumberQ8NBP7
HostHumanized
IsotypeHuman IgG1
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetPCSK9
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Alirocumab biosimilar is a human monoclonal antibody (IgG1 isotype) that targets proprotein convertase subtilisin kexin type 9 (PCSK9), is a PCSK9 inhibitor produced by recombinant DNA technology in Chinese Hamster Ovary cell suspension culture. Alirocuma
Synonyms
Proprotein convertase subtilisin/kexin type 9, NARC-1, PC9
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.